# Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients

> **NCT01241695** · NA · COMPLETED · sponsor: **Fresenius Kabi** · enrollment: 40 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Oral nutritional supplement, food for special medical purposes
- **DIETARY_SUPPLEMENT:** Oral nutritional supplement, food for special medical purposes

## Key facts

- **NCT ID:** NCT01241695
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01241695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01241695, "Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01241695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*